Bio


Zhongxiao Li is a postdoctoral researcher in Professor Ruijiang Li's lab at Stanford Medicine. His research focuses on computational biology and bioinformatics, particularly the development of deep learning methods for computational pathology and spatial transcriptomics/proteomics. Previously, his work has included developing machine learning models for histopathological image analysis, understanding gene regulation, and analyzing biological sequences.

Professional Education


  • Doctor of Philosophy, King Abdullah University of Science and Technology (2024)
  • Master of Science, King Abdullah University of Science and Technology (2020)
  • Bachelor of Science, Southern University of Science & Technology (2018)

Stanford Advisors


All Publications


  • His-MMDM: Multi-Domain and Multi-Omics Translation of Histopathological Images with Diffusion Models ADVANCED SCIENCE Li, Z., Su, T., Zhang, B., Han, W., Zhang, S., Sun, G., Cong, Y., Chen, X., Qi, J., Wang, Y., Zhao, S., Meng, H., Liang, P., Gao, X. 2026: e18066

    Abstract

    Generative AI (GenAI) has advanced computational pathology through various image translation models. These models synthesize histopathological images from existing ones, facilitating tasks such as color normalization and virtual staining. Current models, while effective, are mostly dedicated to specific source-target domain pairs and lack scalability for multi-domain translations. Here, we introduce His-MMDM, a diffusion model-based framework enabling multi-domain and multi-omics histopathological image translation. His-MMDM is not only effective in performing existing tasks such as transforming cryosectioned images to FFPE ones and virtual immunohistochemical (IHC) staining but can also facilitate knowledge transfer between different tumor types and between primary and metastatic tumors. Additionally, it performs genomics- and/or transcriptomics-guided editing of histopathological images, illustrating the impact of driver mutations and oncogenic pathway alterations on tissue histopathology and educating pathologists to recognize them. These versatile capabilities position His-MMDM as a versatile tool in the GenAI toolkit for future pathologists.

    View details for DOI 10.1002/advs.202518066

    View details for Web of Science ID 001669270400001

    View details for PubMedID 41588694

  • PPML-Omics: A privacy-preserving federated machine learning method protects patients' privacy in omic data SCIENCE ADVANCES Zhou, J., Chen, S., Wu, Y., Li, H., Zhang, B., Zhou, L., Hu, Y., Xiang, Z., Li, Z., Chen, N., Han, W., Xu, C., Wang, D., Gao, X. 2024; 10 (5): eadh8601

    Abstract

    Modern machine learning models toward various tasks with omic data analysis give rise to threats of privacy leakage of patients involved in those datasets. Here, we proposed a secure and privacy-preserving machine learning method (PPML-Omics) by designing a decentralized differential private federated learning algorithm. We applied PPML-Omics to analyze data from three sequencing technologies and addressed the privacy concern in three major tasks of omic data under three representative deep learning models. We examined privacy breaches in depth through privacy attack experiments and demonstrated that PPML-Omics could protect patients' privacy. In each of these applications, PPML-Omics was able to outperform methods of comparison under the same level of privacy guarantee, demonstrating the versatility of the method in simultaneously balancing the privacy-preserving capability and utility in omic data analysis. Furthermore, we gave the theoretical proof of the privacy-preserving capability of PPML-Omics, suggesting the first mathematically guaranteed method with robust and generalizable empirical performance in protecting patients' privacy in omic data.

    View details for DOI 10.1126/sciadv.adh8601

    View details for Web of Science ID 001185617600004

    View details for PubMedID 38295178

    View details for PubMedCentralID PMC10830108

  • A unified method to revoke the private data of patients in intelligent healthcare with audit to forget NATURE COMMUNICATIONS Zhou, J., Li, H., Liao, X., Zhang, B., He, W., Li, Z., Zhou, L., Gao, X. 2023; 14 (1): 6255

    Abstract

    Revoking personal private data is one of the basic human rights. However, such right is often overlooked or infringed upon due to the increasing collection and use of patient data for model training. In order to secure patients' right to be forgotten, we proposed a solution by using auditing to guide the forgetting process, where auditing means determining whether a dataset has been used to train the model and forgetting requires the information of a query dataset to be forgotten from the target model. We unified these two tasks by introducing an approach called knowledge purification. To implement our solution, we developed an audit to forget software (AFS), which is able to evaluate and revoke patients' private data from pre-trained deep learning models. Here, we show the usability of AFS and its application potential in real-world intelligent healthcare to enhance privacy protection and data revocation rights.

    View details for DOI 10.1038/s41467-023-41703-x

    View details for Web of Science ID 001083908100005

    View details for PubMedID 37802981

    View details for PubMedCentralID PMC10558551

  • A comprehensive benchmarking with practical guidelines for cellular deconvolution of spatial transcriptomics NATURE COMMUNICATIONS Li, H., Zhou, J., Li, Z., Chen, S., Liao, X., Zhang, B., Zhang, R., Wang, Y., Sun, S., Gao, X. 2023; 14 (1): 1548

    Abstract

    Spatial transcriptomics technologies are used to profile transcriptomes while preserving spatial information, which enables high-resolution characterization of transcriptional patterns and reconstruction of tissue architecture. Due to the existence of low-resolution spots in recent spatial transcriptomics technologies, uncovering cellular heterogeneity is crucial for disentangling the spatial patterns of cell types, and many related methods have been proposed. Here, we benchmark 18 existing methods resolving a cellular deconvolution task with 50 real-world and simulated datasets by evaluating the accuracy, robustness, and usability of the methods. We compare these methods comprehensively using different metrics, resolutions, spatial transcriptomics technologies, spot numbers, and gene numbers. In terms of performance, CARD, Cell2location, and Tangram are the best methods for conducting the cellular deconvolution task. To refine our comparative results, we provide decision-tree-style guidelines and recommendations for method selection and their additional features, which will help users easily choose the best method for fulfilling their concerns.

    View details for DOI 10.1038/s41467-023-37168-7

    View details for Web of Science ID 001001758000003

    View details for PubMedID 36941264

    View details for PubMedCentralID PMC10027878

  • Optimization of binding affinities in chemical space with generative pre-trained transformer and deep reinforcement learning. F1000Research Xu, X., Zhou, J., Zhu, C., Zhan, Q., Li, Z., Zhang, R., Wang, Y., Liao, X., Gao, X. 2023; 12: 757

    Abstract

    Background: The key challenge in drug discovery is to discover novel compounds with desirable properties. Among the properties, binding affinity to a target is one of the prerequisites and usually evaluated by molecular docking or quantitative structure activity relationship (QSAR) models.Methods: In this study, we developed SGPT-RL, which uses a generative pre-trained transformer (GPT) as the policy network of the reinforcement learning (RL) agent to optimize the binding affinity to a target. SGPT-RL was evaluated on the Moses distribution learning benchmark and two goal-directed generation tasks, with Dopamine Receptor D2 (DRD2) and Angiotensin-Converting Enzyme 2 (ACE2) as the targets. Both QSAR model and molecular docking were implemented as the optimization goals in the tasks. The popular Reinvent method was used as the baseline for comparison.Results: The results on the Moses benchmark showed that SGPT-RL learned good property distributions and generated molecules with high validity and novelty. On the two goal-directed generation tasks, both SGPT-RL and Reinvent were able to generate valid molecules with improved target scores. The SGPT-RL method achieved better results than Reinvent on the ACE2 task, where molecular docking was used as the optimization goal. Further analysis shows that SGPT-RL learned conserved scaffold patterns during exploration.Conclusions: The superior performance of SGPT-RL in the ACE2 task indicates that it can be applied to the virtual screening process where molecular docking is widely used as the criteria. Besides, the scaffold patterns learned by SGPT-RL during the exploration process can assist chemists to better design and discover novel lead candidates.

    View details for DOI 10.12688/f1000research.130936.2

    View details for PubMedID 38434657

  • Annotating TSSs in Multiple Cell Types Based on DNA Sequence and RNA-seq Data via DeeReCT-TSS GENOMICS PROTEOMICS & BIOINFORMATICS Zhou, J., Zhang, B., Li, H., Zhou, L., Li, Z., Long, Y., Han, W., Wang, M., Cui, H., Li, J., Chen, W., Gao, X. 2022; 20 (5): 959-973

    Abstract

    The accurate annotation of transcription start sites (TSSs) and their usage are critical for the mechanistic understanding of gene regulation in different biological contexts. To fulfill this, specific high-throughput experimental technologies have been developed to capture TSSs in a genome-wide manner, and various computational tools have also been developed for in silico prediction of TSSs solely based on genomic sequences. Most of these computational tools cast the problem as a binary classification task on a balanced dataset, thus resulting in drastic false positive predictions when applied on the genome scale. Here, we present DeeReCT-TSS, a deep learning-based method that is capable of identifying TSSs across the whole genome based on both DNA sequence and conventional RNA sequencing data. We show that by effectively incorporating these two sources of information, DeeReCT-TSS significantly outperforms other solely sequence-based methods on the precise annotation of TSSs used in different cell types. Furthermore, we develop a meta-learning-based extension for simultaneous TSS annotations on 10 cell types, which enables the identification of cell type-specific TSSs. Finally, we demonstrate the high precision of DeeReCT-TSS on two independent datasets by correlating our predicted TSSs with experimentally defined TSS chromatin states. The source code for DeeReCT-TSS is available at https://github.com/JoshuaChou2018/DeeReCT-TSS_release and https://ngdc.cncb.ac.cn/biocode/tools/BT007316.

    View details for DOI 10.1016/j.gpb.2022.11.010

    View details for Web of Science ID 000962003300011

    View details for PubMedID 36528241

    View details for PubMedCentralID PMC10025762

  • DeeReCT-APA: Prediction of Alternative Polyadenylation Site Usage Through Deep Learning GENOMICS PROTEOMICS & BIOINFORMATICS Li, Z., Li, Y., Zhang, B., Li, Y., Long, Y., Zhou, J., Zou, X., Zhang, M., Hu, Y., Chen, W., Gao, X. 2022; 20 (3): 483-495

    Abstract

    Alternative polyadenylation (APA) is a crucial step in post-transcriptional regulation. Previous bioinformatic studies have mainly focused on the recognition of polyadenylation sites (PASs) in a given genomic sequence, which is a binary classification problem. Recently, computational methods for predicting the usage level of alternative PASs in the same gene have been proposed. However, all of them cast the problem as a non-quantitative pairwise comparison task and do not take the competition among multiple PASs into account. To address this, here we propose a deep learning architecture, Deep Regulatory Code and Tools for Alternative Polyadenylation (DeeReCT-APA), to quantitatively predict the usage of all alternative PASs of a given gene. To accommodate different genes with potentially different numbers of PASs, DeeReCT-APA treats the problem as a regression task with a variable-length target. Based on a convolutional neural network-long short-term memory (CNN-LSTM) architecture, DeeReCT-APA extracts sequence features with CNN layers, uses bidirectional LSTM to explicitly model the interactions among competing PASs, and outputs percentage scores representing the usage levels of all PASs of a gene. In addition to the fact that only our method can quantitatively predict the usage of all the PASs within a gene, we show that our method consistently outperforms other existing methods on three different tasks for which they are trained: pairwise comparison task, highest usage prediction task, and ranking task. Finally, we demonstrate that our method can be used to predict the effect of genetic variations on APA patterns and sheds light on future mechanistic understanding in APA regulation. Our code and data are available at https://github.com/lzx325/DeeReCT-APA-repo.

    View details for DOI 10.1016/j.gpb.2020.05.004

    View details for Web of Science ID 000911135500005

    View details for PubMedID 33662629

    View details for PubMedCentralID PMC9801043